Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors

被引：0
|
作者：
Ferrarini, Alessia [1 ]
Benfaremo, Devis [1 ]
Rossetti, Giulia [1 ]
Morgese, Francesca [2 ]
Pomponio, Giovanni [1 ]
Berardi, Rossana [2 ]
Gabrielli, Armando [1 ]
机构：
[1] Univ Politecn Marche, Clin Med, Dipartimento Sci Clin & Mol, Ancona, Italy
[2] Univ Politecn Marche, Clin Oncol, Dipartimento Sci Clin & Mol, Ancona, Italy
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
11
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [32] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN SPANISH PATIENTS
    Villalobos, L.
    Giraldo-sifuentes, W. A.
    Moran-alvarez, P.
    Arroyo Palomo, J.
    Briones-figueroa, A.
    Rita, C.
    Morell-hita, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 511 - 511
  • [33] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [34] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [35] Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
    Giommoni, Elisa
    Giorgione, Roberta
    Paderi, Agnese
    Pellegrini, Elisa
    Gambale, Elisabetta
    Marini, Andrea
    Antonuzzo, Andrea
    Marconcini, Riccardo
    Roviello, Giandomenico
    Matucci-Cerinic, Marco
    Capaccioli, David
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    IMMUNO, 2021, 1 (03): : 253 - 263
  • [36] Predictors of endocrine immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICI) in routine clinical practice
    Kozhevnikov, Alexander
    Mkrtumyan, Ashot
    Feoktistova, Polina Serrgeevna
    Filonenko, Daria
    Polshina, Natalya
    Volkova, Ekaterina
    Grechukhina, Katerina
    Bykonya, Irina
    Zhukova, Lyudmila
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)
    Tingry, Thomas
    Massy, Emmanuel
    Piperno, Muriel
    Auroux, Maxime
    Kostine, Marie
    Maillet, Denis
    Amini-Adle, Mona
    Fabien, Nicole
    Estublier, Charline
    Goncalves, David
    Girard, Nicolas
    Confavreux, Cyrille B.
    BULLETIN DU CANCER, 2021, 108 (06) : 643 - 653
  • [38] Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors
    Han, Xinyue
    Chen, Yingcui
    Xie, Hong
    Zhang, Yuekai
    Cui, Yu
    Guan, Yaping
    Nie, Weiwei
    Xie, Qi
    Li, Jisheng
    Wang, Baocheng
    Zhang, Bicheng
    Wang, Jun
    BMC CANCER, 2025, 25 (01)
  • [39] Impact of obesity on the risk of immune-related adverse events (irAEs) among patients receiving immune-checkpoint inhibitors (ICI) treatment: A retrospective cohort study
    Elsaid, Mohamed I.
    Paskett, Electra D.
    Shendre, Aditi
    Manne, Ashish
    Li, Lang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Cutaneous immune-related adverse events to checkpoint inhibitors
    Malviya, Neeta
    Tattersall, Ian W.
    Leventhal, Jonathan
    Allon, Allireza
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 660 - 678
12345